Skip to main content
Journal ArticleOPEN ACCESS

Summary of the new EULAR rheumatoid arthritis guideline

  • Chaplin S
Prescriber (2020) 31(9) 15-19
DOI: 10.1002/psb.1863
N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 2019 update of the European League Against Rheumatism (EULAR) recommendations for the management of rheumatoid arthritis with synthetic and biological disease‐modifying anti‐rheumatic drugs takes into account new therapies that have emerged over the past few years. This article summarises the main changes to the guideline.

Cite

CITATION STYLE

APA

Chaplin, S. (2020). Summary of the new EULAR rheumatoid arthritis guideline. Prescriber, 31(9), 15–19. https://doi.org/10.1002/psb.1863

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free